Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00079547 · ClinicalTrials.gov registry record · Phase 4
The Safety and Effectiveness of Low and High Carbohydrate Diets
A Phase 4 study of Obesity, sponsored by Temple University.
- Completed
- Registry status
- Phase 4
- Development phase
- 307
- Enrollment target
- 3
- Study locations
NCT00079547 is a Phase 4 study of Obesity that has completed, run by Temple University. The registered enrollment target is 307 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (63% lower). The trial reports 3 study locations across 3 states.
The verdict
NCT00079547, a Phase 4 study of Obesity, has completed, sponsored by Temple University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 307 participants
- Enrollment target
- 3
- Study locations
Study Summary
This study will compare the safety and the effectiveness of a low carbohydrate diet (Atkins diet) with a high carbohydrate diet (conventional USDA diet).
Conditions Studied
Interventions
- BEHAVIORAL Low-calorie diet
- BEHAVIORAL low-carbohydrate diet
Study Locations (3)
Colorado
- University of Colorado - Denver
Missouri
- Washington University - St Louis
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 307 participants |
| Start Date | 2003-04 |
| Est. Completion | 2008-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00079547
The ClinicalTrials.gov registry entry for NCT00079547 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 307 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (63% lower). The listed sponsor is Temple University, which has 163 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Low-calorie diet is the first listed.
NCT00079547 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Colorado, Missouri, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00079547 about?
NCT00079547 is a clinical study titled "The Safety and Effectiveness of Low and High Carbohydrate Diets". This study will compare the safety and the effectiveness of a low carbohydrate diet (Atkins diet) with a high carbohydrate diet (conventional USDA diet).
What is the current status of trial NCT00079547?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 307 participants. The study started on 2003-04. Estimated completion is 2008-03.
What conditions does trial NCT00079547 study?
This clinical trial studies the following conditions: Obesity.
What interventions are being tested in trial NCT00079547?
The interventions under investigation include: Low-calorie diet (BEHAVIORAL), low-carbohydrate diet (BEHAVIORAL).
Who is sponsoring clinical trial NCT00079547?
This trial is sponsored by Temple University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00079547 being conducted?
This trial has 3 study locations across Colorado, Missouri, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Effects of Mirabegron and Tadalafil on Glucose Tolerance in Prediabetics
RECRUITING · Phase 4
-
Phenotype-Tailored Lifestyle Intervention for Obesity: A Randomized Trial
RECRUITING · Phase 4
-
Effect of Naltrexone Hydrochloride ER and Bupropion Hydrochloride ER Combination (Contrave®/Mysimba®) on Major Adverse Cardiovascular Events (MACE)
RECRUITING · Phase 4
-
Weight Loss Study: Genetics and Response to Naltrexone/Bupropion
RECRUITING · Phase 4
-
Fibrosis Lessens After Metabolic Surgery
RECRUITING · Phase 4
-
Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.